• THE NETWORK
    • About MPN AN
    • Steering Committee and Team
    • Membership
    • Members
    • Newsletter
    • News
  • ABOUT MPNs
    • What are MPNs?
    • Prevalence
    • Clinical trials
  • ACTIVITIES & CAMPAIGNS
    • MPN Horizons Conference
    • MPN Awareness Day
    • MPN Advocates Network Global Survey
    • MPNAN Webinars
    • Blood Cancer Patient Advocates Academy
  • CONTACT US
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • THE NETWORK
    • About MPN AN
    • Steering Committee and Team
    • Membership
    • Members
    • Newsletter
    • News
  • ABOUT MPNs
    • What are MPNs?
    • Prevalence
    • Clinical trials
  • ACTIVITIES & CAMPAIGNS
    • MPN Horizons Conference
    • MPN Awareness Day
    • MPN Advocates Network Global Survey
    • MPNAN Webinars
    • Blood Cancer Patient Advocates Academy
  • CONTACT US

In the News

Dr. Ruben Mesa offers guidance to MPN Patients about the Coronavirus (Covid-19)

by Lawrence Mouawad | Mar 13, 2020 | In the News, Webinar

Dr. Ruben Mesa, Director, Mays Cancer Center, UT Health San Antonio, MD Anderson, offers guidance for patients with myeloproliferative neoplasms (MPNs) in dealing with the Coronavirus (Covid-19).  

An MPN Update with Drs Ruben Mesa and Robyn Scherber

by Lawrence Mouawad | Feb 3, 2020 | In the News, Webinar

Dr. Ruben Mesa and Dr. Robyn Scherber hematologists from the Mays Cancer Center, home to UT Health San Antonio MD Anderson discuss the latest updates regarding new treatments for myeloproliferative neoplasms (MPNS) including essential thrombocythemia (ET),...

Best of MPN News at ASH 2019

by Lawrence Mouawad | Jan 10, 2020 | In the News, Webinar

The MPN Advocates Network’s Giora Sharf interviews Dr. Ruben Mesa from the UT Health San Antonio MD Anderson Cancer Center San Antonio, Texas about the biggest MPN updates we learned at ASH 2019.   

Patient Power Interviews Dr. Ruben Mesa about Fedratinib Approval

by Lawrence Mouawad | Aug 21, 2019 | In the News, Webinar

“BREAKING NEWS: The FDA has approved fedratinib as a new treatment option for myelofibrosis patients. Watch now as our Editorial and Community Director, Rebecca Seago-Coyle, sits down with Dr. Ruben Mesa, Director of Mays Cancer Center at UT Health San Antonio...

Recent Posts

  • New Free Online Course for Patient Advocates: “Interaction with Newly Diagnosed Patients”
  • In Conversation with… The Steering Committee Members of the MPN Advocates Network
  • WEBINAR: “Latest News from EHA 2024”
  • Frontiers in MPNs
  • Save the date for MPN Horizons 2024 Conference

Recent Comments

No comments to show.

Sign up to our Newsletter today!

Subscribe me!

Become a member of MPNAN

Click for more

Contact Us

MPN Advocates Network
c/o Münzgraben 6, P.O.B. 453, CH-3000 Bern 7, Switzerland
info (at) mpn-advo... .net

Follow Us

@GMPNAN
MPNAdvocatesNetwork
MPN Advocates Network

Search

MPN Advocates Network © 2025